Skip to content
Screener

Generate Biomedicines, Inc. GENB Balance Sheet Statement

Q2 '26Q1 '26Q4 '25Q2 '25Q1 '25
$135.36M-12.3%$160.58M-27.2%$121.65M$154.27M$220.61M
$322.06M$356.07M$99.85M
$470.25M$535.39M$234.37M
$27.31M$27.84M$29.15M
$561.69M$625.74M$330.18M
$5.65M$7.62M+1,376%$3.84M-$597K
$0$4.51M
$3.74M$4.31M
$56.64M$58.39M$82.2M
$105.65M$110.94M$141.55M
$128K$33K
-$804.99M-$737.74M-$676.29M
$456.05M+188%$514.8M+209%-$615.97M-41.8%-$517.85M-$471M
$561.69M$625.74M$330.18M

FAQ

What are Generate Biomedicines, Inc.'s total assets?
Generate Biomedicines, Inc. (GENB) holds $561.7M in total assets.
How much debt does Generate Biomedicines, Inc. have?
Generate Biomedicines, Inc. carries $62.6M in total debt against $456.0M of shareholders' equity, a debt-to-equity ratio of 0.14.
How much cash does Generate Biomedicines, Inc. have?
Generate Biomedicines, Inc. holds $135.4M in cash and equivalents.
Can Generate Biomedicines, Inc. cover its short-term obligations?
Its current ratio is 8.30 — current assets exceed current liabilities.
Where does Generate Biomedicines, Inc.'s balance sheet data come from?
Every line is extracted from Generate Biomedicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.